Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lankester

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Genes and Immunity|March 11, 2011
Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotideH Ijspeert, A C Lankester, J M van den Berg, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Blood Advances|January 16, 2026
Acquired non-permissive BM microenvironment impairs HSCs proliferation and maintenance and B-cell development post-HSCTMelanie de Gier, Jakov Korzhenevich, Franziska Schmidt, et al.
Bone Marrow Transplantation|April 7, 2005
Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunityM J D van Tol, E C J Claas, B Heemskerk, et al.
Bone Marrow Transplantation|January 27, 2015
Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCTV Kosmoliaptsis, M M Jöris, D H Mallon, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation|May 4, 2021
Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamideLisa V E Oostenbrink, Emma S Pool, Cornelia M Jol-van der Zijde, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2021
Hematopoietic stem cell transplantation in a patient with proteasome-associated autoinflammatory syndrome (PRAAS)Dorit Verhoeven, Dieneke Schonenberg-Meinema, Frédéric Ebstein, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor BiologyDavid M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Hematology/Oncology and Stem Cell Therapy|March 24, 2020
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?Lisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Genes and Immunity|March 11, 2011
Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotideH Ijspeert, A C Lankester, J M van den Berg, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Blood Advances|January 16, 2026
Acquired non-permissive BM microenvironment impairs HSCs proliferation and maintenance and B-cell development post-HSCTMelanie de Gier, Jakov Korzhenevich, Franziska Schmidt, et al.
Bone Marrow Transplantation|April 7, 2005
Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunityM J D van Tol, E C J Claas, B Heemskerk, et al.
Bone Marrow Transplantation|January 27, 2015
Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCTV Kosmoliaptsis, M M Jöris, D H Mallon, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation|May 4, 2021
Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamideLisa V E Oostenbrink, Emma S Pool, Cornelia M Jol-van der Zijde, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2021
Hematopoietic stem cell transplantation in a patient with proteasome-associated autoinflammatory syndrome (PRAAS)Dorit Verhoeven, Dieneke Schonenberg-Meinema, Frédéric Ebstein, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor BiologyDavid M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Hematology/Oncology and Stem Cell Therapy|March 24, 2020
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?Lisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, et al.
Pageof 21